Research programme: central nervous system disorder therapeutics - Neurocrine Biosciences

Drug Profile

Research programme: central nervous system disorder therapeutics - Neurocrine Biosciences

Alternative Names: G protein-coupled receptor and ion channel modulators - Neurocrine Biosciences; G protein-coupled receptor modulators - Neurocrine Biosciences

Latest Information Update: 06 Apr 2017

Price : $50

At a glance

  • Originator Neurocrine Biosciences
  • Class
  • Mechanism of Action G protein-coupled receptor modulators; Ion channel modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Neurological disorders
  • Research Epilepsy; Essential tremor; Pain
  • Discontinued Hypothyroidism; Psychotic disorders

Most Recent Events

  • 14 Feb 2017 Early research in Epilepsy in USA before February 2017 (Neurocrine Biosciences form 10-K, filed in February 2017)
  • 14 Feb 2017 Early research in Essential tremor in USA before February 2017 (Neurocrine Biosciences form 10-K, filed in February 2017)
  • 14 Feb 2017 Early research in Pain in USA before February 2017 (Neurocrine Biosciences form 10-K, filed in February 2017)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top